Aims-To study the impact of confirmed rotavirus infection at a paediatric hospital; to use the data to obtain a mi imum estimate of the cost of treating reported cases of rotavirus in England and Wales. Methods-Data were obtained on all patients with rotavirus over a two year period. Information was collected on 386 patients with rotavirus infection who were treated at the 120 bed Queen
£95 400 a year. One hundred and forty eight (38%) patients were admitted to the wards and a further 49 patients developed symptoms while in hospital. Intravenous infusion was required by 18 patients. The mean duration of hospital stay was 5 5 days. One March) (fig 1) . HRV (fig 3) . Three hundred and forty five (93%) of the infections were in children under 2 years, among whom were 41 infants aged under 4 months. Infection was sufficiently severe to necessitate admission to hospital in 17 (41%) patients in this age group; two patients aged 2 months required intravenous infusion. A further nine cases were believed to be hospital acquired as they had been admitted more than three days before the onset of diarrhoea.
Only 18 of 386 (5%) patients required intravenous infusion; 15 cases were due to serotype G1, two to serotype G4, and one to serotype G2. The five patients infected with serotype G8 were all treated with oral rehydration solutions in the casualty unit.
An estimate of the cost of treating 337 patients with confirmed HRV infection at QEH are presented in fig 4. Many of the patients who attended the casualty unit were given oral rehydration fluids, advice on how to use them, and told to return if symptoms did not resolve. Those with more severe dehydration (148 of 337, 44%) were admitted to the infectious diseases ward where isolation facilities are available.
There was no evidence of a nosocomial outbreak of HRV infection during the period of the study, but a further 49 sporadic cases occurred on four of the other wards in the hospital. Thirty one of these were on a general paediatric ward which treats patients under 2 years of age. Many of these cases resulted in a prolonged stay in hospital and a reduction in the availability of beds.
Detailed information was readily available on the database for 118 of 148 patients admitted to the observation ward. The total number of bed days was 654, with a mean (SD) duration of stay of 5-5 (4 5 -~b udgets are often under immense strain. This is compounded by the fact that the peak of admissions of children with bronchiolitis due to respiratory syncytial virus occurs at the same time. Our findings indicated that 2-7% of all admissions (casualty plus the infectious diseases ward) to QEH were due to HRV. This is remarkably similar to the findings (2 2%-4-6%) of a 10 year study on the impact of rotavirus infection at the 328 bed Texas Children's Hospital.' It is frequently stated that HRV infections in infants aged up to 3 months are either asymptomatic or mild56 but in the present survey and at the Texas Hospital, a significant number of the patients requiring hospital treatment were in this age group, (7 0% and 13-3%, respectively). In two patients (both aged 2 months) admitted to QEH dehydration was severe, necessitating intravenous infusion, and in a previous outbreak on a special care baby unit in another hospital, several deaths occurred due to HRV (Cubitt and Holzel, unpublished data).
The mean duration of hospital stay for patients with HRV was 5-5 days at QEH and 5-3 days at the Texas Children's Hospital. Further comparison can be made of the costs of treating inpatients at the two hospitals. At QEH this was estimated to be £158 a day, excluding the cost of medical staff, and at Texas Children's Hospital US$603, based on the average revenue per operating bed. The minimum cost, based on treating 386 patients with HRV over 2 years at QEH is estimated at £95 420 a year compared with > US$ 1 500 000 to treat 473 patients a year at the 328 bed children's hospital in the USA.
In 1991, 13 260 cases of HRV were reported to the CDSC by laboratories in England and Wales. Most of these cases were from patients treated in hospital and therefore do not take into account the large number of cases treated by general practitioners. The extent of the problem in the general community was shown by a study in the USA in which it was estimated that 25 work or school days per 100 children are lost each year and that 14% of all children are treated by a doctor for HRV associated diarrhoea.7 Extrapolating from our estimates in the present study, in which 49% of the patients were treated in hospital and 51% in casualty, the cost (excluding cost of medical staff) of treating the 13 260 confirmed HRV cases is in excess of £6-3 million a year. It has to be borne in mind that these represent only a minute fraction of HRV infections occurring in the community as a whole. It is evident from these limited studies that the true cost of HRV infections to health services is enormous. This illustrates the need for continued research and dissemination of knowledge about oral rehydration solutions so that children can be treated at home or by general practitioners rather than being admitted to hospital. This may prove to be a more cost effective strategy than vaccination against HRV. As there is an increasing emphasis on the cost of health provision in the United Kingdom there is a need for an indepth study to determine the true impact of HRV in the community at large.
